4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-24-000200
Director sold 7,750 shares at $28.54 ($221,185)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pande Atul Director | 2024-12-02 | Sale 10b5-1 | −7,750 | $28.54 | $221,185 | 86,663 | D |
| Open-market sales · 7,750 sh · avg $28.54 · $221,185 | |||||||
Loading xslF345X05/wk-form4_1733347352.xml…